Publications

Selective inhibitors of Hepatitis C virus replication

Postconditioning and Debio-025 Prevent LV Remodelling and Reduce Mortaility Following Acute Myocardial Infarction in Mice

Cyclosporine increases Human Immunodeficiency virus Type 1 Vector Transduction of Primary Mouse Cells

In Vivo and in Vitro Effects of Debio-025, a non-immunosuppressive Cyclosporin A Derivative on Duchene Muscular Dystrophy

Hepatoprotection by Cyclosporin A in Experimental Hepatitis. Sorting Desensitization of the Mitochondrial Permeablility Transition Pore from Immunosuppression

The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases

The non-immunosuppressive Cyclosporin A analogue Debio-025 is a potent inhibitor of Hepatitis C virus replication in vitro

Debio-025 is a Promising New Drug for the Treatment of Chronic Hepatitis C

ZT-1 for the Symptomatic Treatment of Mild to Moderate Alzheimer´s Disease: Preliminary Results of a Multicenter, Randomised, Double-blind Placebo and…